1096 related articles for article (PubMed ID: 30767754)
21. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
22. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
[TBL] [Abstract][Full Text] [Related]
24. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
[TBL] [Abstract][Full Text] [Related]
25. Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities.
Neves AP; da Silva GB; Vargas MD; Pinheiro CB; Visentin Ldo C; Filho JD; Araújo AJ; Costa-Lotufo LV; Pessoa C; de Moraes MO
Dalton Trans; 2010 Nov; 39(42):10203-16. PubMed ID: 20871881
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
27. Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with
Hildebrandt J; Häfner N; Görls H; Barth MC; Dürst M; Runnebaum IB; Weigand W
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743112
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands.
Bakalova A; Buyukliev R; Tcholakova I; Momekov G; Konstantinov S; Karaivanova M
Eur J Med Chem; 2003 Jun; 38(6):627-32. PubMed ID: 12832135
[TBL] [Abstract][Full Text] [Related]
29. Mixed natural arylolefin-quinoline platinum(II) complexes: synthesis, structural characterization and in vitro cytotoxicity studies.
Chi NTT; Thong PV; Mai TTC; Van Meervelt L
Acta Crystallogr C Struct Chem; 2018 Dec; 74(Pt 12):1732-1743. PubMed ID: 30516159
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
31. Novel Bidentate Amine Ligand and the Interplay between Pd(II) and Pt(II) Coordination and Biological Activity.
Oliveira LS; Rosa LB; Affonso DD; Santos IA; Da Silva JC; Rodrigues GC; Harris M; Jardim ACG; Nakahata DH; Sabino JR; de Carvalho JE; Miguel DC; Ruiz ALTG; Abbehausen C
Chembiochem; 2024 Mar; 25(6):e202300696. PubMed ID: 38146865
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, spectral characterization of novel Pd(II), Pt(II) π-coordination compounds based on N-allylthioureas. Cytotoxic properties and DNA binding ability.
Repich HH; Orysyk VV; Palchykovska LG; Orysyk SI; Zborovskii YL; Vasylchenko OV; Storozhuk OV; Biluk AA; Nikulina VV; Garmanchuk LV; Pekhnyo VI; Vovk MV
J Inorg Biochem; 2017 Mar; 168():98-106. PubMed ID: 28086144
[TBL] [Abstract][Full Text] [Related]
34. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
Sun Y; Wei H; Zhang Q; Zhao X
Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
[TBL] [Abstract][Full Text] [Related]
36. DNA-binding and in vitro cytotoxic activity of platinum(II) complexes of curcumin and caffeine.
Censi V; Caballero AB; Pérez-Hernández M; Soto-Cerrato V; Korrodi-Gregório L; Pérez-Tomás R; Dell'Anna MM; Mastrorilli P; Gamez P
J Inorg Biochem; 2019 Sep; 198():110749. PubMed ID: 31200320
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
39. Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes.
Arenaza-Corona A; Couce-Fortúnez MD; de Blas A; Morales-Morales D; Santillan R; Höpfl H; Rodríguez-Blas T; Barba V
Inorg Chem; 2020 Oct; 59(20):15120-15134. PubMed ID: 33000942
[TBL] [Abstract][Full Text] [Related]
40. Novel nickel(II), palladium(II), and platinum(II) complexes having a pyrrolyl-iminophosphine (PNN) pincer: Synthesis, crystal structures, and cytotoxic activity.
Kim Y; Lee J; Son YH; Choi SU; Alam M; Park S
J Inorg Biochem; 2020 Apr; 205():111015. PubMed ID: 32032825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
